Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 10,129-10,140 of 23,847
Drug study icon
CompletedNCT07269886

BIOMARKERS FOR DRUG SELECTION IN DEPRESSION

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

In Buenos Aires
DepressionOtherFrom 18 Years to 65 Years
Countries
Argentina
Sponsor
Neomente SAS
Condition
Depression
Biological study icon
Active Not RecruitingNCT06581822

Biomarkers for Pharmacoresponse in Bipolarity - Coagulation

This observational study is following people with bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Stockholm
BipolarityOtherFrom 18 Years to 100 Years
Countries
Sweden
Sponsor
Karolinska Institutet
Condition
Bipolarity
Biological study icon
CompletedNCT02033382

Biomarkers in First Episode Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New York
SchizophreniaOtherFrom 16 Years to 40 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
Drug study icon
CompletedNCT00817336

Biomarkers in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Orangeburg
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Drug study icon
CompletedNCT05650775

Biomarkers of ADHD Treatment Response

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Brookline
ADHDDrugFrom 7 Years to 11 Years
Countries
United States
Sponsor
Boston Children's Hospital
Condition
ADHD
Drug study icon
CompletedNCT03118193

Biomarkers of Antidepressant Resistance

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

In Tours
DepressionOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Tours
Condition
Depression
Drug study icon
CompletedNCT03323437

Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In New York
SchizophreniaDrugFrom 18 Years to 35 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Schizophrenia
Other study type icon
CompletedNCT06796712

BiomeBakery Project

This summary needs review. Please check the official study record and contact the research team for details.

In Reading
AnxietyOtherFrom 60 Years to 75 Years
Countries
United Kingdom
Sponsor
University of Reading
Condition
Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.